Galvanize Therapeutics, Inc. — Form D/A
Galvanize Therapeutics, Inc. of SAN CARLOS, CA, a company, filed a Form D amendment with the SEC on 2020-10-29. The offering totals $16.1M, of which $6.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-10-29
- Form: D/A
- Accession: 0001808246-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.1M
- Amount sold: $6.1M
- Remaining: $10.0M
- Investors: 1
- Date of first sale: 2020-03-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364148
Issuer
- Name: Galvanize Therapeutics, Inc.
- CIK: 0001808246
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1531 INDUSTRIAL RD, SAN CARLOS, CA, 94070
- Phone: 650-268-4252
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Seth Harrison | Director | Redwood City, CA |
| Jonathan Waldstreicher | Director | Redwood City, CA |
| Jonathan Waldstreicher | Executive Officer | Redwood City, CA |
Other filings by this issuer (1)
More